Background {#Sec1}
==========

People with chronic conditions must be capable of self-management to protect their own health. Healthcare providers should provide support for patients facing health challenges who need assistance \[[@CR1]\]. However, compliance with complex regimens and the self-care behavior of diabetic patients worsen over the long-term with lifestyle changes \[[@CR2], [@CR3]\]. This is a serious problem for both patients and healthcare providers. Therefore, medical staff should understand the factors influencing patients' self-management behavior.

Self-management of type 2 diabetes mellitus (T2DM), which involves adherence to medical instructions on diet and nutrition, physical activity, medication regimen, and weight and stress management, is necessary for treating T2DM \[[@CR4]--[@CR6]\]. Adherence to diabetes therapy can improve patients' blood glucose control and help them avoid long-term complications \[[@CR1], [@CR7]--[@CR9]\]. Furthermore, many studies have shown a strong association between diabetes perception and diabetes control \[[@CR10]--[@CR12]\].

Adherence to medical instructions and glycemic control are affected by several factors such as knowledge about diabetes \[[@CR13]\], self-efficacy \[[@CR14]--[@CR17]\], depression \[[@CR18]--[@CR20]\], medical beliefs \[[@CR21], [@CR22]\], medical cost, and social support. Disease perception is thought to be an important psychosocial factor that can motivate patients to self-manage their diabetes. Their perception of the illness is formed by the cause, duration, awareness of symptoms, and controllability of the disease, along with a patient-created schematic diagram of the disease. Many studies have demonstrated that the illness perception of diabetic patients influences their self-care behavior \[[@CR23]--[@CR25]\], but little quantitative research concerning a relationship between medication adherence and illness perceptions of T2DM was found.

Illness perception questionnaires for various medical conditions have been developed recently to examine patients' perceptions about their diseases, symptoms, and causes \[[@CR26]\]. Kamatani et al. \[[@CR27]\] reported that T2DM patients form perceptions of diabetes in a similar manner to disease acceptance; they addressed this issue for T2DM in Japan by creating a new illness perception questionnaire (asking about the patient's diabetic profile) for understanding the patients' perception of their disease. They studied the relationship between blood glucose control and the T2DM patients' perception of their disease. Although some patient and treatment characteristics are predictive of lower adherence in therapy, characteristics of patients' perceptions associated with anti-diabetic treatments nonadherence remain unclear. The patient's perceptions of diabetes may offer new insights into glycemic control variations in T2DM patients. Further, healthcare providers can focus on behavioral approaches to managing T2DM by understanding the patients' illness perception.

The primary aim of this study was to investigate the relationship between patients' perceptions of T2DM and medication adherence. Secondary aims were (1) to categorize a behavioral subphenotypes of medication adherence in T2DM using a custom medication adherence assessment tool, developed by Ueno et al. (2) to report the behavioral profile associated with the behavioral subphenotypes of medication adherence,, and (3) to investigate the relationship between behavioral subphenotypes of medication adherence in T2DM.

Methods {#Sec2}
=======

A cross-sectional study using a questionnaire was conducted from October 2015 to September 2017. This study included adults who were (1) aged over 20 years, (2) diagnosed with T2DM for at least one year, and (3) outpatients of a community pharmacy or a hospital in the Ishikawa Prefecture. The patients were recruited at a community pharmacy (Aozora Pharmacy) or at the Japan Community Healthcare Organization (JCHO) Kanazawa Hospital and Kanazawa University Hospital. After obtaining informed written consent, data was collected using an interview questionnaire that had four domains, namely: (1) demographic and clinical characteristics, (2) medication adherence, (3) illness perceptions about diabetes, and (4) diabetes knowledge.

The experimental methods were approved by the Kanazawa University of Medicine Ethics Committee and the JCHO Kanazawa Hospital Ethics Committee. All work was conducted in accordance with the Declaration of Helsinki and ethical principles for clinical research. Written informed consent was obtained from all patients.

Demographic and clinical characteristics {#Sec3}
----------------------------------------

We collected data on patients' age, sex, body mass index (BMI), diabetes duration, family history of diabetes, microvascular complications, important comorbidities, and treatment modalities (different types of insulin therapy). Their glycemic control levels (HbA1c), number of medications, number of doses per day, history of microvascular complications, and important comorbidities were obtained from the chart data. The microvascular complication status was defined as the presence of retinopathy, neuropathy, or nephropathy.

Medication adherence {#Sec4}
--------------------

Ueno et al. \[[@CR28]\] developed new medication adherence scale factors (subscale factor 1: collaboration with healthcare providers; subscale factor 2: motivation for collecting and utilizing medication-related information and utilization of information regarding medication; subscale factor 3: agreement with taking medication and its fit with their lifestyle; subscale factor 4: current state of medication use) and evaluated their reliability and validity. Medication adherence was assessed using the Ueno method. The medication adherence scale can be used with all items or each of the four subscale areas alone. The total score and the sum of each of the four subscale regions were calculated, and a higher score represents better medication implementation. The contents of each of the four subscale regions in the entire medication adherence were also evaluated. The medication adherence questionnaire about diabetes was shown in Additional file [1](#MOESM1){ref-type="media"}: Table S1.

Illness perceptions about diabetes {#Sec5}
----------------------------------

The illness perception questionnaire, developed by Kamatani et al. \[[@CR27]\], was used to collect data on the participants' perceptions of their diabetes. The questionnaire consisted of 29 items and 7 factors (factor 1: feeling of inferiority; factor 2: living an orderly life; factor 3: feeling of restriction; factor 4: feeling miserable; factor 5: feeling of getting into trouble; factor 6: feeling of overindulgence; factor 7: feeling of importance). The questionnaire for illness perceptions about diabetes was shown in Additional file [2](#MOESM2){ref-type="media"}: Table S2.

Diabetes knowledge {#Sec6}
------------------

We used the revised Michigan Diabetes Knowledge Scale (DKT) \[[@CR29]\] to measure the patients' knowledge of diabetes treatment. The revised DKT comprises a 20-item tool with two subscales. The first 18 questions comprise the general diabetes knowledge section for patients with either type 1 diabetes or T2DM. The insulin use subscale comprises two items and is only appropriate for use with patients being treated with insulin. Thus, we used only the general knowledge subscale because this study enrolled T2DM patients regardless of the treatment regimen. The revised Michigan Diabetes Knowledge Scale (DKT) was shown in Additional file [3](#MOESM3){ref-type="media"}: Table S3.

Statistical procedures and analyses {#Sec7}
-----------------------------------

The significance of the demographic characteristic differences among the study patients was assessed using the Mann--Whitney U test or Fisher's exact test between two sets of observations, and the Kruskal--Wallis test was performed for three or more variables. The statistical significance of the individual differences was evaluated using Haberman's residual analysis and the Bonferroni method if the analysis of variance was significant. The relationships between the total medication adherence score and the patient characteristics were analyzed using Spearman's rho statistic (ρ).

Principal component analysis (PCA) and cluster analyses were performed for the total cohort. Medical adherence patterns were extracted with PCA using the correlation matrix. To determine the number of retained components, the proportion of the variance explained by the components was used. In particular, two components were retained because they explained 85% of the medication adherence. For multiple group comparisons of patient perception and patient characteristics between medication adherence groups, we used analysis of variance. For correlations among age, BMI, family history of diabetes, two factors of illness perceptions about diabetes (factor 2: living an orderly life and factor 6: feeling of overindulgence), and diabetes knowledge, Spearman's correlation coefficient was used. Subsequently, we conducted multiple regression analyses with medication adherence as the dependent variable.

Data from the questionnaires were analyzed using the Statistical Package for Social Sciences (SPSS version 25; IBM Japan, Tokyo, Japan), with a *p*-value \< 0.05 considered statistically significant.

Results {#Sec8}
=======

Demographic/clinical characteristics and illness perceptions about diabetes and diabetes-specific knowledge {#Sec9}
-----------------------------------------------------------------------------------------------------------

A total of 90 and 67 patients with T2DM participated in the hospital and community settings, respectively. The participants' demographics in each setting are shown in Table [1](#Tab1){ref-type="table"}**.** The two groups were comparable regarding diabetes duration, diabetes knowledge, and patient's perceptions; however, the mean age and the proportion of the females in the community pharmacy patients were higher than those of the hospital patients. Moreover, more of the hospital patients received insulin treatments than the community pharmacy patients. The mean age for the total sample population was 65.8 years, and the sample population was comprised of 69.2% men. The patients' median BMI was 24.0. The sex distribution and age of this sample population were different from those of the whole population of the hospital and community pharmacy. The median duration of diabetes in the sample population was 11.0 years. A positive family history of diabetes mellitus was reported by 55.3% of the sample population. Approximately 30% of the sample population reported having complications, including diabetic retinopathy (8.8%), diabetic nephropathy (6.3%), diabetic neuropathy (10.1%), and cardiac problems (11.3%). Insulin therapy was administered to 34% of the patients. The number of doses taken by the patients was 8 per day, and 5 medications were prescribed. The average total score of knowledge about the disease (general features of diabetes, diet, physical activity, and complications) was 9.8 (out of a maximum of 18 on the general knowledge subscale).Table 1Demographic and clinical characteristics of patients with type 2 diabetes at study entryTotalHospital\
(*n* = 92)Community pharmacy\
(*n* = 67)*p*-value^a^*n*%*n*%*n*%Gendermale11069.27278.33856.70.005\*female4930.82021.72943.3Age (year)median\
\[range\]68\
\[32--88\]65\[32--87\]70\[42--88\]0.001\*BMImedian\
\[range\]24.0\
\[15.2--34.8\]24.0\[15.9--34.8\]24.0\[15.2--34.0\]0.446Diabetes Duration (year)median\
\[range\]11,0\
\[0--55\]12.0\[0--55\]10.0\[1--53\]0.447HbA1c\
(%)median\
\[range\]7.0\
\[4.4--10.6\]7.0\
\[4.4--10.0\]7.1\
\[5.9--10.6\]0.364Diabetes history of relativesyes8855.34852.2400.420no7144.74447.827Complicationsretinopathy148.899.857.50.779nephropathy106.388.723.00.193neuropathy1610.188.7811.90.596cardiovascular1811.31112.0710.40.806non10666.76267.44567.20.923Therapyexercise therapy5232.73335.91928.40.393diet therapy7144.74751.12435.8.0.075insulin therapy5434.04043.51420.90.004\*Diabetes knowledge\
(the general knowledge subscale)average (SD)\
\[range\]9.8\
(3.4)\
\[0--16\]10.4\
(2.4)\
\[4--16\]8.9\
(4.2)\
\[0--16\]0.050Number of medicationsmedian\
\[range\]5\
\[1--20\]5\
\[1--20\]5\
\[1--17\]0.577*Number* of doses *per day*median\
\[range\]8\
\[0--50\]9\
\[1--50\]8\
\[0--28\]0.137Patient's perceptionFactor 1. Feeling of inferiority3.1\
(2.3)\
\[0--10\]3.0\
(2.2)\
\[0--8\]3.2\
(2.5)\
\[0--10\]0.745Factor 2. Living a tidy life6.9\
(2.1)\
\[0--10\]7.1\
(2.1)\
\[0--10\]6.8\
(2.1)\
\[1--10\]0.195Factor 3. Feeling of restriction5.2\
(1.9)\
\[0.2--9\]4.9\
(1.9)\
\[0.2--8.6\]5.5\
(1.7)\
\[1--9\]0.076Factor 4. Feeling miserable5.3\
(2.1)\
\[0--10\]5.6\
(2.1)\
\[0--10\]4.9\
(2.1)\
\[0--9.67\]0.028Factor 5. Feeling of getting into trouble3.9\
(1.9)\
\[0--9.67\]3.8\
(1.7)\
\[0--7.17\]3.9\
(2.2)\
\[0--9.67\]0.919Factor 6. Feeling of intemperance6.2\
(1.9)\
\[0--10\]6.4\
(1.7)\
\[2.33--10\]6.1\
(2.2)\
\[0--9.33\]0.797Factor 7. Feeling of portentous6.5\
(2.0)\
\[0.67--10\]6.8\
(1.6)\
\[2.33--10\]6.0\
(2.3)\
\[0.67--10\]0.013^a^Mann--Whitney U-test or Fisher's exact test was used to test the mean difference between individuals at hospital and community pharmacy; *Pearson's* chi-square test was used to test the distribution difference of categories between individuals at hospital and community pharmacy

Clustering medication adherence behavior {#Sec10}
----------------------------------------

Table [2](#Tab2){ref-type="table"} shows the correlation between the total medication adherence score and patient characteristics. Significant relationships were found between medication adherence and BMI, family history of diabetes, diabetes knowledge, and two factors of patient's perception (factor 2: living an orderly life and factor 6: feeling of overindulgence).Table 2The correlation between the total medication adherence score and patient characteristicsTotal medication adherence scorecoefficient of Spearman's correlation*p*-valueSex0.0180.821Age (years)0.0980.217BMI−0.1710.031\*Diabetes duration (years)0.1540.053HbA1c (%)− 0.0410.658Family history of diabetes0.2440.002\*Complications retinopathy0.1190.134 nephropathy0.0080.919 neuropathy0.0660.41 cardiovascular0.1360.088 non−0.1010.206Therapy exercise therapy0.0680.397 diet therapy0.1120.159 insulin therapy−0.0290.72Diabetes knowledge0.1690.033\*Number of medications0.1140.185Number of doses per day0.1540.073Patients' perception Factor 1. Feeling of inferiority−0.1190.134 Factor 2. Living an orderly life0.2530.001\*\* Factor 3. Feeling of restriction0.0590.461 Factor 4. Feeling miserable0.0390.63 Factor 5. Feeling of getting into trouble0.0640.428 Factor 6. Feeling of overindulgence0.2050.009\*\* Factor 7. Feeling of importance0.0350.665\*significant at 0.05 level, \*\*significant at 0.01 level

We investigated the profile of medication adherence in T2DM patients according to the medication adherence behavior. Considering that medication adherence has four subscale factors, the score for each subscale factor showed a characteristic for each patient with the same degree of adherence. Therefore, patients were classified into clusters by using a subordinate scale factor of medication adherence. We used PCA to reduce the number of medication adherence variables to a smaller number of independent dimensions. The varimax rotation was used to simplify the PC extracted, and the medication adherence between diabetic patients after the projection of variables and that of diabetic patients represented by components 1 and 2, respectively, were summarized**.** The corresponding eigenvalues give the information percentages explained by these factors, namely, 52.5 and 23.8% for diabetic patients after the projection of variables and diabetic patients represented by components 1 and 2, respectively) (Table [3](#Tab3){ref-type="table"}). Table [3](#Tab3){ref-type="table"} also shows three factors of adherence: subscale factor 1: collaboration with healthcare providers; subscale factor 2: motivation for collecting and using medication-related information; subscale factor 3: agreement to take medication and its fit with their lifestyle, which contribute strongly to component 1; and, by contrast, subscale factor 4 (the current state of medicine use) provided a large contribution to component 2. Therefore, in this result, components 1 and 2 were respectively named as "accessibility to medical treatment" and "status of taking medicines" for convenience.Table 3Component loadings for medical adherence in varimax rotation principal componentsComponent 1Component 2Subscale factor 1: collaboration with healthcare providers0.77−0.434Subscale factor 2: motivation of collecting and utilizing medication-related information and utilization of information regarding medication0.834−0.34Subscale factor 3: agreement with taking medication and its fit with their lifestyle0.730.311Subscale factor 4: the current state of medication use0.5260.742% cumulative variance52.523.8Positive signs indicate that higher values of the variable are influential in the component, whereas negative signs indicate the influence of lower values

The scores of these two principal components were used for the cluster analysis (CA) by dividing the patient cohort into four groups. Table [4](#Tab4){ref-type="table"} shows the CA comparison of the four groups of variables. The first group (group 1) was characterized by high accessibility to medical treatment, the second group (group 2) demonstrated medium accessibility to medical treatment, the third group (group 3) had a high level of adherence for taking medicines, and the fourth group (group 4) showed low medication adherence. Figure [1](#Fig1){ref-type="fig"} shows the scatter plot of all the patients. The X-axis (component 1) is mainly determined by variable prevalence and accessibility to medical treatment, whereas the Y-axis (component 2) is mainly determined by the level of medicine adherence (the variable adherence). Table [5](#Tab5){ref-type="table"} shows the patient characteristics for each group. The age, BMI, family history of diabetes, and the two factors of a patient's perception (factor 2: living an orderly life and factor 6: feeling of overindulgence) of this cohort were significantly different in the four groups. The characteristics of the groups with good adherence (group1 and 3) were older and lower BMI than that of the poor adherence group. Moreover, patients in the good adherence groups have strong tendencies to live an orderly life and overindulgence about diabetes.Table 4Defining characteristics of the clustersMedication adherenceGroup 1\
(*n* = 58)Group 2\
(*n* = 17)Group 3\
(*n* = 66)Group 4\
(*n* = 18)Component1\
Accessibility to medical treatment0.870860.26542−0.61106−1.47487Component 2\
Status of taking medicines−0.01329−1.228980.82345−1.44393Fig. 1Projection of variables on the first plan given by Principal Component Analysis (PCA)Table 5Patient characteristics for each groupGroup1Group2Group3Group4*p*-value^a^*n*%*n*%*n*%*n*%Gendermale4568.21376.54069.01266.70.917female2131.8423.51831.0633.3Age (year)median68(10.3)65(11.6)69(10.7)60(13.6)0.011\*\[range\]\[34--88\]\[32--76\]\[42--88\]\[35--83\]BMImedian\
\[range\]23.4\
\[15.2--34.8\]23.5\
\[15.9--29.6\]24.7\
\[18.6--34.0\]26.2\
\[17.7--32.7\]0.014\*Diabetes duration (year)median\
\[range\]15\
\[0--53\]10\
\[1--25\]11\
\[0--55\]10\
\[1--25\]0.270HbA1c (%)median\
\[range\]7.0\
\[4.4--9.2\]7.4\
\[5.6--10.0\]6.9\
\[5.9--10.6\]7.4\
\[5.8--9.9\]0.111Diabetes history of relatives of Relativesyes4568.21058.82441.4950.00.026\*no2131.8741.23458.6950.0ComplicationsDiabetic retinopathy812.115.958.600.00.419Nephropathy46.100.0610.300.00.264Neuropathy812.1317.658.600.00.316Heart disease1218.215.946.915.60.150none4162.11270.63763.81788.90.176TherapyExercise therapy2233.3529.41831.0738.90.923Dietary Therapy2943.91058.82543.1738.90.638Insulin therapy2030.3847.11831.0844.40.424Number of medicationsmedian\
\[range\]5\
\[5.6--10.0\]5\
\[1--13\]5\
\[1--15\]6\
\[2--11\]0.849*Number* of doses *per day*median\
\[range\]9\
\[1--28\]7\
\[1--23\]8\
\[0--50\]8\
\[2--20\]0.543Diabetes knowledgeaverage (SD)\
\[range\]10.5\
(2.9)\
\[0--16\]10\
(2.1)\
\[5--13\]9.0\
(4.0)\
\[0--15\]9.3\
(3.3)\
\[0--14\]0.321Patient's perceptionFactor 1. Feeling of inferiority2.9\
(2.3)\
\[0--8\]2.9\
(2.0)\
\[0--6.6\]3.1\
(2.4)\
\[0--10\]3.8\
(2.3)\
\[0--8\]0.515Factor 2. Living a tidy life7.5\
(1.8)\
\[3--10\]6.6\
(1.2)\
\[5--9\]6.8\
(2.3)\
\[0--10\]5.6\
(2.4)\
\[1--9.33\]0.012\*Factor 3. Feeling of restriction5.3\
(1.9)\
\[0.8--9\]5.9\
(1.7)\
\[1--7.8\]5.0\
(1.9)\
\[0.2--8\]4.8\
(1.9)\
\[1--7.4\]0.209Factor 4. Feeling miserable5.3\
(2.1)\
\[0--9.33\]5.4\
(1.8)\
\[2.33--9.33\]5.4\
(2.3)\
\[0--10\]5.1\
(2.0)\
\[1.67--9\]0.980Factor 5. Feeling of getting into trouble4.0\
(2.2)\
\[0--9.33\]4.2\
(1.7)\
\[0.83--7\]3.9\
(1.7)\
\[0.5--9.67\]3.1\
(1.6)\
\[0--6.33\]0.282Factor 6. Feeling of overindulgence6.7\
(1.9)\
\[0--10\]6.2\
(1.7)\
\[4--10\]6.0\
(1.9)\
\[0.67--9.33\]5.4\
(1.9)\
\[2.33--9\]0.044\*Factor 7. Feeling of portentous6.4\
(1.8)\
\[2--10\]7.3\
(1.4)\
\[4.33--10\]6.5\
(2.3)\
\[0.67--10\]5.9\
(1.9)\
\[2--9\]0.181^a^Kruskal--Wallis test was used to test the mean difference among four groups. *Fisher's* exact test wa*s* used to test the distribution difference of categories between individuals at the hospital and the community pharmacy. BMI, body mass index. \*significant at 0.05 level

Association between medication adherence and demographic/clinical characteristics, illness perceptions about diabetes, and diabetes-specific knowledge in patients {#Sec11}
------------------------------------------------------------------------------------------------------------------------------------------------------------------

Multiple regression analysis was performed to analyze predictors of medication adherence. BMI, family history of diabetes, one factor of patient's perception (factor 2: living an orderly life), and diabetes knowledge were found to be significant predictors of medication adherence of patients with T2DM (Table [6](#Tab6){ref-type="table"}).Table 6Multivariable regression analysis for medication adherenceVariablesBSEβPatients' perception factor 2: Living an orderly life0.9700.3070.239\*\*Family history of diabetes3.3921.250−0.198\*\*Diabetes knowledge0.5040.1920.199\*\*BMI−0.3910.170−0.17\**BMI* body mass index, B, partial regression coefficient for the constant in the null model. SE, the standard error around the coefficient for the constant. β, standard partial regression coefficient. \*Significant at 0.05 level. \*\*Significant at 0.01 level. The coefficient of determination (R2) in this regression equation was 0.195

The explanatory variables of interest were BMI, family history of diabetes, patient's perception, and diabetes knowledge. Table [7](#Tab7){ref-type="table"} presents results of the multinomial logistic regression analysis of factors associated with adherence to medications by using group 1 (high level of adherence to medications) as a reference. There was a significant correlation between patients' perception of disease/diabetes knowledge and medication adherence. A low level of adherence to medications (group 4) was associated with patient's perception (odds ratio (OR) = 0.697; 95% confidence interval (CI): 0.523--0.930). A medium level of adherence to medications (group 3) was associated with high BMI (OR = 1.159; 95% CI: 1.034--1.300) and poor diabetes knowledge (OR = 0.844; 95% CI: 0.741--0.961).Table 7Multinomial logistic regression results in medication adherence groupsVariablesBOdds ratio95% confidence intervallowerupperGroup 2 Age−0.055\*0.9460.8990.996 BMI−0.0780.9250.7871.088 Family history of diabetes−0.3501.4190.4474.506 Patients' perception factor 2: living an orderly life−0.2570.7730.5721.045 Diabetes knowledge−0.0490.9520.7891.150Group 3 Age0.0001.0000.9631.040 BMI0.148\*1.1591.0341.300 Family history of diabetes−1.250\*\*3.4901.5807.709 Patients' perception factor 2: living an orderly life−0.1210.8860.7221.087 Diabetes knowledge−0.169\*0.8440.7410.961Group 4 Age−0.072\*\*0.9310.8820.982 BMI0.1221.1300.9611.328 Family history of diabetes−0.6181.8550.5526.239 Patients' perception factor 2: living an orderly life−0.361\*0.6970.5230.930 Diabetes knowledge−0.1800.8350.6931.006BMI, body mass index; B. Partial regression coefficient; The coefficient of determination (R^2^) in this regression equation was 0.273. \*significant at 0.05 level, \*\*significant at 0.01 level

Discussion {#Sec12}
==========

We found that our study T2DM cohort was to categorize to four distinct subphenotypes according to a behavioral subphenotypes of medication adherence in T2DM patients using a validated medication adherence scale and moreover the good adherence group was significantly associated with the patient's perception of "living an orderly life."

Diabetic patients adherence to their medication schedules more closely if they believe in medication efficacy and perceive their illness as manageable \[[@CR29]--[@CR34]\]. Patients with hypertension strongly believe that hypertension can be controlled by medical treatment \[[@CR35], [@CR36]\] or by managing their diets and lifestyle \[[@CR37]\]; therefore, they strongly adhere to antihypertensive medications. Satisfaction, convenience, and effectiveness were associated with a good medication adherence in patients with dyslipidemia \[[@CR38]\].

Measuring patient perception by Kamatani's method showed that diabetic patients who lived an orderly life had good medication adherence. Better adherence might be related to beliefs in medication efficacy and illness perceptions. Patients' perceptions change their viewpoint regarding life with T2DM, i.e., whether life goes forward depends on the disease or on their own initiative to live life responsibly. We hypothesized that positive recognition of diabetes and/or understanding of diabetes could be positively associated with the good medication adherence of T2DM patients. Therefore, we suggested devising strategies to promote illness perception that will help patients develop a customized diabetes health plan.

As another predictor of medical adherence in T2DM patients, BMI, diabetes knowledge, and family history of diabetes were identified. Tominaga et al. reported that older age was significantly associated with better medication adherence \[[@CR39]\]. A high BMI (obesity) and a family history of diabetes are significantly and positively associated with the risk of T2DM progression \[[@CR40]--[@CR42]\]. A previous report showed that a family history of DM is associated with lower physical activity and noncompliance with dietary advice \[[@CR43]--[@CR45]\]. Diabetic patients' knowledge of their disease is one of the important determinants of self-management practices. This relationship is very important in diabetes intervention for medical providers and patients because knowledge of diabetes and self-management practice are significantly related to glycemic control \[[@CR46], [@CR47]\].

There is a correlation between disease perception and health outcomes because self-management is complex. It involves complicated decision making that depends on the patients' perception of their illness in terms of whether it is controllable, understandable, curable, or serious \[[@CR48]--[@CR50]\]. We hypothesize that a poor adherence group can change their adherence to diabetes treatment by developing the perception of "living an orderly life."

This study has several limitations. The responses from the questionnaires were based on self-declaration; therefore, they are prone to potential errors and misunderstanding of the questions. In particular, the results of medication adherence may be subjected to recall bias and social desirability bias, especially when it comes to sensitive questions such as medication adherence. A cross-sectional design with convenience sampling was adopted in this study. There is a difference in the baseline characteristics of patients in the hospital vs. community settings, such as age and gender, considering that patients who have been visiting a pharmacy for a long time might readily agree to participate in this study. This could be a limitation as selection bias might have occurred for participants from the pharmacy.

Conclusions {#Sec13}
===========

We found that medication adherence in patients with T2DM is presumed by BMI, diabetes knowledge, family history of diabetes, and the diabetic patient's perception of "living an orderly life." Patients who have a perception of "living an orderly life" have good medication adherence. It may be beneficial to tailor health risk communications targeting T2DM to match the recipients' personality characteristics instead of using the "one-size-fits-all" approach. Future prospective studies are required to confirm the therapeutic effects of behavioral interventions for the perception of diabetes.
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